# John Feehally

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-feehally/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,020 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 68 |
| i10-index | 188 |
| Last Known Institution | University of Leicester |
| OpenAlex ID | https://openalex.org/A5061037871 |
| Works | 374 |

## Researcher papers

Showing 12 of 23.

- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology](https://scholariq.org/papers/international-society-of-nephrology-s-0by25-initiative-for-acute-kidney-injury/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-clinical-outcomes-in-patients-with-iga/)
- [Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments](https://scholariq.org/papers/validation-of-the-oxford-classification-of-iga-nephropathy-in-cohorts-with/)
- [Assessment of Global Kidney Health Care Status](https://scholariq.org/papers/assessment-of-global-kidney-health-care-status/)
- [Evaluating a New International Risk-Prediction Tool in IgA Nephropathy](https://scholariq.org/papers/evaluating-a-new-international-risk-prediction-tool-in-iga-nephropathy/)
- [Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study](https://scholariq.org/papers/recognition-and-management-of-acute-kidney-injury-in-the-international-society/)
- [Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial](https://scholariq.org/papers/targeted-release-budesonide-versus-placebo-in-patients-with-iga-nephropathy/)
- [IgA Nephropathy](https://scholariq.org/papers/iga-nephropathy-3/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Leicester](https://scholariq.org/institutions/university-of-leicester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.